Sp1 transcription factor: A long-standing target in cancer chemotherapy

C Vizcaíno, S Mansilla, J Portugal - Pharmacology & therapeutics, 2015 - Elsevier
Abstract Sp1 (specificity protein 1) is a well-known member of a family of transcription factors
that also includes Sp2, Sp3 and Sp4, which are implicated in an ample variety of essential …

Phytotherapeutics in cancer invasion and metastasis

B Salehi, P Zucca, M Sharifi‐Rad… - Phytotherapy …, 2018 - Wiley Online Library
Cancer is a multifactorial disease, and therefore, a multitarget approach is needed to face
the complex cancer biology, based on the combined use of different natural and synthetic …

Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma

G Bidkhori, Z Narimani, S Hosseini Ashtiani, A Moeini… - PloS one, 2013 - journals.plos.org
Our goal of this study was to reconstruct a “genome-scale co-expression network” and find
important modules in lung adenocarcinoma so that we could identify the genes involved in …

[PDF][PDF] Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients

PH Yin, X Liu, YY Qiu, J Cai, J Qin, HR Zhu… - Asian Pacific journal of …, 2012 - Citeseer
Background It's been 50 years since chemotherapy was introduced into the clinical practice
of cancer treatment. Chemotherapy has been successful in the treatment of some forms of …

Natural products as mechanism‐based anticancer agents: Sp transcription factors as targets

S Safe, R Kasiappan - Phytotherapy Research, 2016 - Wiley Online Library
Naturally occurring anticancer agents and their derivatives act on multiple pathways to
inhibit carcinogenesis and their inhibition of migration, invasion, growth, survival, and …

Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targets

JL Liggett, X Zhang, TE Eling, SJ Baek - Cancer letters, 2014 - Elsevier
Non-steroidal anti-inflammatory drugs (NSAIDs) are used extensively for analgesic and
antipyretic treatments. In addition, NSAIDs reduce the risk and mortality to several cancers …

Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target

S Safe, P Imanirad, S Sreevalsan, V Nair… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Specificity protein (Sp) transcription factors (TFs) are members of the
Sp/Kruppel-like factor family, and Sp proteins play an important role in embryonic and early …

Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2

M Acunzo, G Romano, D Palmieri… - Proceedings of the …, 2013 - National Acad Sciences
In the past decade, we have observed exciting advances in lung cancer therapy, including
the development of targeted therapies. However, additional strategies for early detection …

Decursinol angelate inhibits LPS-induced macrophage polarization through modulation of the NFκB and MAPK signaling pathways

SU Islam, JH Lee, A Shehzad, EM Ahn, YM Lee… - Molecules, 2018 - mdpi.com
Inflammation is considered the root cause of various inflammatory diseases, including
cancers. Decursinol angelate (DA), a pyranocoumarin compound obtained from the roots of …

Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action

Y Jiang, Y Zhang, J Luan, H Duan, F Zhang… - Cytotechnology, 2010 - Springer
Bufalin, a naturally occurring small-molecule compound from Traditional Chinese Medicine
(TCM) Chansu showed inhibitory effects against human prostate, hepatocellular …